Horizon Pharma reported 355.2M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Aerie Pharmaceuticals AERI:US $ 34.54M 1.94M
ALKERMES ALKS:US 139.19M 14.02M
Amgen AMGN:US $ 1.38B 130M
AstraZeneca AZN:LN 2.57B 76M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Cara Therapeutics CARA:US $ 5.65M 683K
Coherus Biosciences CHRS:US $ 40.34M 954K
Eli Lilly And LLY:US $ 1.69B 109.7M
Endo International Ordinary Shares ENDP:US 170.93M 12.7M
Flexion Therapeutics FLXN:US $ 27.41M 189K
Horizon Pharma HZNP:US 355.2M 23.21M
JAZZ PHA JAZZ:US 429.03M 168.52M
Merk MRK:US $ 2.25B 376M
Novartis NOVN:VX 3.71B 190M
Pacira Pharmaceuticals PCRX:US $ 50.81M 2.29M
Perrigo Ordinary Shares PRGO:US 271.9M 3M
Pfizer PFE:US $ 2.79B 134M
Prestige Brands PBH:US $ 61.91M 1.67M
Revance Therapeutics RVNC:US $ 49.01M 937K
Supernus Pharmaceuticals SUPN:US $ 69.54M 8.08M
Takeda 4502:JP 219.84B 14.55B
Teva Pharmaceutical Industries TEVA:US 832M 16M
Valeant Pharmaceuticals VRX:CN C$ 685M 79M
Xeris Pharmaceuticals Inc XERS:US $ 25.93M 6.85M
Zoetis ZTS:US $ 495M 86M